secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2021-08-17T23:59:59+00:00
Accession:  0001021771-21-000066
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative Therapies shareholders approve reverse stock split, reject Nevada reincorporation
--------------------------------------------------------------------------------

- Elected Nickolay Kukekov as Class I director: 1.49B for, 132.6M withheld, 452M broker non-votes.
- Approved 2021 Stock Incentive Plan: 1.33B for, 210M against, 80.8M abstentions.
- Rejected reincorporation from Delaware to Nevada: 1.48B for but 4.4M abstentions, needed majority; broker non-votes 452M.
- Authorized Board to effect reverse stock split at ratio 1:20 to 1:4000 with discretion; 1.65B for, 396M against.
- Ratified Friedman LLP as auditor for FY2021: 1.93B for, 90.2M against, 50M abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000102177121000066/0001021771-21-000066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000102177121000066/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001021771-21-000066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer